echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > C2i Genomics partners with Twist Bioscience to launch reference material for genome-wide cancer detection

    C2i Genomics partners with Twist Bioscience to launch reference material for genome-wide cancer detection

    • Last Update: 2022-03-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Cancer intelligence company C2i Genomics and Twist Bioscience recently announced a collaboration to develop genome-wide cancer reference materials


    A major obstacle faced by diagnostic laboratories and regulatory agencies in cancer diagnosis today is the lack of standardized reference samples for analytical validation when performing genome-wide analysis in the laboratory


    Under the collaboration agreement, C2i will utilize artificial intelligence (AI) to identify a large number of variants associated with cancer signatures across the genome


    Dr.


    Reference standards can also be used to train samples and adjust the C2i algorithm for analysis of patient samples


    Asaf Zviran, CEO and co-founder of C2i Genomics, said: "C2i is committed to advancing the availability of genome-wide cancer detection and monitoring, thereby supporting researchers and clinicians to improve the treatment of patients with oncology


    Before the partnership with Twist, C2i had shown strong momentum over the past year


    About C2i Genomics


    Founded in 2019, C2i Genomics has created the world's leading intelligent platform for cancer therapy that utilizes low starting volumes of blood (only 2mL of blood) for whole-genome sequencing, capable of providing 100x higher detection sensitivity than other liquid biopsy companies


    About Twist Bioscience


    Twist Bioscience is a leading and fast-growing synthetic biology and genomics company developing game-changing DNA synthesis platforms to advance the industrialization of bioengineering



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.